Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes

Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: صبا نیکان فر , کبری حمدی , سانیا حیاتی لاله , ناصر صمدی , وحیده شهنازی , امیر فتاحی , محمد نوری

کلمات کلیدی: Follicular fluid, Oncostatin M, Oocyte maturation, Polycystic ovary syndrome

نشریه: 29374 , 2022 , 22 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله امیر فتاحی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز سلولهای بنیادی
کد مقاله 78301
عنوان فارسی مقاله Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes
عنوان لاتین مقاله Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

The role of adipokines in ovarian-related disorders such as polycystic ovary syndrome (PCOS) has been reported. However, the involvement of Oncostatin M (OSM), a recently identified adipokine, in ovarian function is unknown. Therefore, we investigated the association of the OSM signaling pathway with ovarian functions and PCOS pathogenesis. This case-control study enrolled 30 PCOS and 30 healthy women who underwent the intracytoplasmic sperm injection procedure. OSM and OSM receptor (OSMR) levels were evaluated in the follicular fluid (FF). Moreover, the expression of insulin receptor substrates (IRS1 and IRS2), OSM, OSMR, suppressor of cytokine signaling 3 (SOCS3), and androgen receptor (AR) genes were analyzed in the isolated cumulus cells (CCs). For the in-vitro experiment, the effect of recombinant OSM on the expression of related genes in isolated CCs was analyzed. Follicular concentrations of OSM and OSMR were significantly lower in PCOS (123.91±48.58 pg/ml and 0.93±0.35 ng/ml, respectively) compared to control women (283.53 ± 96.62 pg/ml and 1.45 ± 0.18 ng/ml, respectively; p < 0.001) and were positively correlated with the oocyte maturation (r = 0.611 and r = 0.611, respectively) and fertilization (r = 0.592 and r = 0.627, respectively) rates in the PCOS group. Furthermore, the SOCS3 expression was upregulated about eight times in PCOS patients compared to the controls (p < 0.05). The treatment of cells with recombinant OSM significantly increased SOCS3, OSMR, IRS-1, and -2 expression and decreased AR expression. The decreased levels of OSM and its receptor in PCOS patients, possibly mediated by SOCS3, could negatively affect oocyte maturation and fertilization rates.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
صبا نیکان فراول
کبری حمدیدوم
سانیا حیاتی لالهسوم
ناصر صمدیچهارم
وحیده شهنازیپنجم
امیر فتاحیششم
محمد نوریهفتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Oncostatin M (2).pdf1400/12/253079485دانلود